STOCK TITAN

Arcturus Therapeutics to Attend Upcoming Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Arcturus Therapeutics (Nasdaq: ARCT), a commercial mRNA medicines company specializing in infectious disease vaccines and liver and respiratory rare diseases, has announced its participation in three upcoming investor conferences in December 2024. The company will participate in a fireside chat at the Piper Sandler 36th Annual Healthcare Conference on December 3 at 4:30 p.m. ET, attend Citi's 2024 Global Healthcare Conference on December 4, and join another fireside chat at the 7th Annual Evercore HealthCONx Conference on December 5 at 8:45 a.m. ET. Webcast links will be available on the company's website under the Investor Relations/Events section.

Arcturus Therapeutics (Nasdaq: ARCT), un'azienda commerciale di medicinali a base di mRNA specializzata in vaccini contro le malattie infettive e nelle malattie rare del fegato e respiratorie, ha annunciato la sua partecipazione a tre conferenze per investitori in programma a dicembre 2024. L'azienda parteciperà a una conversazione informale durante la 36a Conferenza Sanitaria Annuale di Piper Sandler il 3 dicembre alle 16:30 ET, sarà presente alla Conferenza Sanitaria Globale 2024 di Citi il 4 dicembre e parteciperà a un'altra conversazione informale alla 7a Conferenza Annuale Evercore HealthCONx il 5 dicembre alle 8:45 ET. I link per la trasmissione in diretta saranno disponibili sul sito web dell'azienda nella sezione Relazioni con gli Investitori/Eventi.

Arcturus Therapeutics (Nasdaq: ARCT), una empresa de medicamentos de ARN mensajero que se especializa en vacunas contra enfermedades infecciosas y en enfermedades raras del hígado y respiratorias, ha anunciado su participación en tres conferencias de inversores que se llevarán a cabo en diciembre de 2024. La empresa participará en un chat informal en la 36ª Conferencia Anual de Atención Médica de Piper Sandler el 3 de diciembre a las 4:30 p.m. ET, asistirá a la Conferencia Global de Atención Médica 2024 de Citi el 4 de diciembre y se unirá a otro chat informal en la 7ª Conferencia Anual Evercore HealthCONx el 5 de diciembre a las 8:45 a.m. ET. Los enlaces para la transmisión estarán disponibles en el sitio web de la empresa en la sección de Relaciones con Inversores/Eventos.

Arcturus Therapeutics (Nasdaq: ARCT)은 감염병 백신 및 간과 호흡기 희귀 질환에 특화된 상업용 mRNA 의약품 회사로, 2024년 12월에 예정된 세 가지 투자자 회의에 참여한다고 발표했습니다. 이 회사는 12월 3일 오후 4시 30분 ET에 파이퍼 샌들러 제36회 연례 의료 회의에서 프라이드 사이드 채팅에 참여하며, 12월 4일 시티의 2024년 글로벌 의료 회의에 참석하고, 12월 5일 오전 8시 45분 ET에 열리는 제7회 에버코어 헬스CONx 회의에서 또 다른 프라이드 사이드 채팅에 참여할 예정입니다. 웹캐스트 링크는 회사 웹사이트의 투자자 관계/이벤트 섹션에서 확인할 수 있습니다.

Arcturus Therapeutics (Nasdaq: ARCT), une entreprise de médicaments à base d'ARNm spécialisée dans les vaccins contre les maladies infectieuses ainsi que dans les maladies rares du foie et respiratoires, a annoncé sa participation à trois conférences pour investisseurs à venir en décembre 2024. L'entreprise participera à un chat informel lors de la 36e Conférence Annuelle sur la Santé de Piper Sandler le 3 décembre à 16h30 ET, assistera à la Conférence Mondiale sur la Santé 2024 de Citi le 4 décembre, et rejoindra un autre chat informel lors de la 7e Conférence Annuelle Evercore HealthCONx le 5 décembre à 8h45 ET. Les liens de webdiffusion seront disponibles sur le site Web de l'entreprise dans la section Relations avec les Investisseurs/Événements.

Arcturus Therapeutics (Nasdaq: ARCT), ein Unternehmen für kommerzielle mRNA-Medikamente, das sich auf Impfstoffe gegen Infektionskrankheiten sowie auf seltene Leber- und Atemwegserkrankungen spezialisiert hat, hat seine Teilnahme an drei bevorstehenden Investorenkonferenzen im Dezember 2024 bekannt gegeben. Das Unternehmen wird am 3. Dezember um 16:30 Uhr ET an einem Fireside Chat auf der 36. jährlichen Gesundheitskonferenz von Piper Sandler teilnehmen, am 4. Dezember an der 2024 Global Healthcare Conference von Citi teilnehmen und am 5. Dezember um 8:45 Uhr ET an einem weiteren Fireside Chat auf der 7. jährlichen Evercore HealthCONx-Konferenz teilnehmen. Die Links zur Webübertragung sind auf der Website des Unternehmens im Bereich Investorenbeziehungen/Veranstaltungen verfügbar.

Positive
  • None.
Negative
  • None.

SAN DIEGO--(BUSINESS WIRE)-- Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a commercial messenger RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases, today announced that the Company will participate in the following investor conferences:

Piper Sandler 36th Annual Healthcare Conference (Fireside Chat)

  • Tuesday, December 3, 2024 (4:30 p.m. ET)

Citi’s 2024 Global Healthcare Conference (Attending)

  • Wednesday, December 4, 2024

7th Annual Evercore HealthCONx Conference (Fireside Chat)

  • Thursday, December 5, 2024 (8:45 a.m. ET)

Webcast links can be found under Investor Relations/Events section of Arcturus’ website.

About Arcturus

Founded in 2013 and based in San Diego, California, Arcturus Therapeutics Holdings Inc. (Nasdaq: ARCT) is a commercial mRNA medicines and vaccines company with enabling technologies: (i) LUNAR® lipid-mediated delivery, (ii) STARR® mRNA Technology (sa-mRNA) and (iii) mRNA drug substance along with drug product manufacturing expertise. Arcturus developed KOSTAIVE®, the first self-amplifying messenger RNA (sa-mRNA) COVID vaccine in the world to be approved. Arcturus has an ongoing global collaboration for innovative mRNA vaccines with CSL Seqirus, and a joint venture in Japan, ARCALIS, focused on the manufacture of mRNA vaccines and therapeutics. Arcturus' pipeline includes RNA therapeutic candidates to potentially treat ornithine transcarbamylase (OTC) deficiency and cystic fibrosis (CF), along with its partnered mRNA vaccine programs for SARS-CoV-2 (COVID-19) and influenza. Arcturus' versatile RNA therapeutics platforms can be applied toward multiple types of nucleic acid medicines including messenger RNA, small interfering RNA, circular RNA, antisense RNA, self-amplifying RNA, DNA, and gene editing therapeutics. Arcturus' technologies are covered by its extensive patent portfolio (over 400 patents and patent applications in the U.S., Europe, Japan, China, and other countries). For more information, visit www.ArcturusRx.com. In addition, please connect with us on Twitter and LinkedIn.

Arcturus Therapeutics

Public Relations & Investor Relations

Neda Safarzadeh

VP, Head of IR/PR/Marketing

(858) 900-2682

IR@ArcturusRx.com

Source: Arcturus Therapeutics Holdings Inc.

FAQ

What investor conferences will Arcturus Therapeutics (ARCT) attend in December 2024?

Arcturus will attend three conferences: Piper Sandler Healthcare Conference (Dec 3), Citi's Global Healthcare Conference (Dec 4), and Evercore HealthCONx Conference (Dec 5).

When is Arcturus Therapeutics' (ARCT) fireside chat at the Piper Sandler conference?

Arcturus' fireside chat at the Piper Sandler Healthcare Conference is scheduled for Tuesday, December 3, 2024, at 4:30 p.m. ET.

Where can investors find the webcast links for Arcturus' (ARCT) December 2024 conference presentations?

Webcast links can be found in the Investor Relations/Events section of Arcturus' website.

Arcturus Therapeutics Holdings Inc.

NASDAQ:ARCT

ARCT Rankings

ARCT Latest News

ARCT Stock Data

467.26M
24.80M
8.46%
90.18%
16.91%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
SAN DIEGO